NEWS DETAIL

O Jaypirca, da Eli Lilly, recebeu parecer favorável do Comitê de Medicamentos para Uso Humano (CHMP) na Europa para o tratamento da leucemia linfocítica crônica (LLC).

O pedido de aprovação do Jaypirca foi submetido à Comissão Europeia e espera-se uma decisão dentro de um a dois meses.

Informações médicas

该文章暂未提取到完整正文,已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。

ผลิตภัณฑ์ที่เกี่ยวข้องกับบทความนี้

ระบบจับคู่ผลิตภัณฑ์เหล่านี้โดยอัตโนมัติจากชื่อเรื่อง บทสรุป และเนื้อหาบทความ

คำถามที่พบบ่อย

Which products are related to this article?

The system matched these relevant products from the article content: สั่งซื้อยา Lucius Pirtobrutinib ออนไลน์.

How can I view the medicines discussed in this article?

Use the related product cards below the article to review available specifications, prices, product information, and reviews.

Does this article replace advice from a doctor or pharmacist?

No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.

WhatsApp WhatsApp WeChat WeChat